Survival of the fittest! Sadly this also applies to cancer cells. It is anticipated that strategies pinpointing competitive cell interactions in various phases and microenvironments of cancers might help to suppress cancer initiation, expansion, and progression. In this cross-journal collection, we welcome original articles focusing on tumor cell competition research.
Onco-proteogenomics has great promise and holds the key in improving our understanding of cancer biology and it is anticipated that the routine utilization of this integrated omics approach would become one of the gold standards of precision oncology. In this cross-journal collection, we welcome original articles focusing on cancer proteogenomics research.
Polyploid giant cancer cells (PGCCs), as a subset of cells among the tumor cell populations, can arise in response to therapy-induced stress. Upon stress cessation, PGCCs could eventually generate more aggressive progeny that repopulate the tumor, resembling the properties of cancer stem cells. It is hoped that advancing our knowledge in this area could help to identify the vulnerabilities of PGCCs to improve the therapeutic efficacy. In this cross-journal collection, we welcome original articles focusing on polyploid giant cancer cell research.
Cancer Cell International, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. Read more here.
Domenico Coppola, Moffitt Cancer Center and Florida Digestive Health Specialists, USA
Yasumasa Kato, Ohu University, Japan
Andy TY Lau, Shantou University Medical College, China
2021 marked the 20th year since Cancer Cell International published its very first articles. To mark the occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 20 years.
Click here to view which articles have been shared the most in the last month!
Discover the range of academic oncology titles at Springer Nature here.
Your browser needs to have JavaScript enabled to view this timeline
Citation Impact
6.436 - 2-year Impact Factor (2021)
5.999 - 5-year Impact Factor (2021)
1.065 - Source Normalized Impact per Paper (SNIP)
1.099 - SCImago Journal Rank (SJR)
Speed
14 days to first decision for all manuscripts (Median)
35 days to first decision for reviewed manuscripts only (Median)
Usage
1,622,016 Downloads (2021)
1,273 Altmetric mentions (2021)
03 February 2022
16 April 2021
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).